Navigation Links
FDA Grants Orphan Drug Status to Merrimack Pharmaceuticals' MM-398, a Nanotherapeutic Encapsulation of Irinotecan, for the Treatment of Pancreatic Cancer
Date:8/1/2011

CAMBRIDGE, Mass., Aug. 1, 2011 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted MM-398 orphan drug status for the treatment of pancreatic cancer. MM-398 is a novel, stable nanotherapeutic encapsulation of the marketed chemotherapy drug irinotecan.  MM-398 is partnered with PharmaEngine, Inc. for development and commercialization in Taiwan under the designation PEP02.

(Logo:  http://photos.prnewswire.com/prnh/20100913/NE63515LOGO)

One of the purposes of the Orphan Drug Designation program is to provide orphan status to drugs and biologics intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the United States.  In the United States, the company that first obtains FDA approval for a designated orphan drug for the specified rare disease or disorder receives orphan drug marketing exclusivity for that drug for a period of seven years. This orphan drug exclusivity prevents the FDA from approving another application, including a full new drug application (NDA), to market the same drug for the same orphan indication, except in very limited circumstances.  Orphan drug designation in the United States also provides for a reduction in regulatory fees and additional regulatory support for research and development initiatives.

About PharmaEngine, Inc.

PharmaEngine is a biopharmaceutical company established in Taipei, Taiwan in 2003.  The company focuses on the development of new drugs to treat cancer and Asian prevalent diseases.  For further information on PharmaEngine, please visit the Company's website at http://www.pharmaengine.com.

About Merrimack

Merrimack is a biopharmaceutical company discovering, developing and pre
'/>"/>

SOURCE Merrimack Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. UCLA Receives Six UC Health Quality Grants to Improve Hospital Care
2. China Grants COPAN Patent for Flocked Swabs
3. Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation
4. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
5. FDA Formally Accepts Dune Medicals MarginProbe™ System Pre-Market Approval (PMA) Application and Grants Expedited Review Status
6. FDA Grants Orphan Drug Designation for Mithridions MCD-386CR to Treat Progressive Supranuclear Palsy
7. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
8. FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration
9. FDA Grants 510(k) Clearance to Life Technologies Stem Cell Growth Medium
10. Court Grants Preliminary Approval to Class Action Settlement that Provides Benefits Of Approximately $20 Million to Healthcare Providers that Purchased a SS1 Before January 1, 2009
11. Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Inc. (Vanda) (NASDAQ: VNDA ) today announced that ... of the Year by the Tech Council of ... 25 th Annual Tech Awards Celebration held in ... the leaders and innovators in the technology and life science ... regions. "We are deeply honored to receive ...
(Date:5/23/2013)... Nephros, Inc. (OTC Bulletin Board: ... develops and sells high performance liquid purification ultrafilters, announced ... addition, the concurrent temporary reduction in exercise price for ... 2013. Nephros estimates that it will receive ... A portion of the proceeds will be used for ...
(Date:5/23/2013)... , May 23, 2013  Hadasit Bio-Holdings Ltd. ... of biotech companies, based on intellectual property developed ... Israel ,s foremost medical research center, today ... Ltd., received significant funding from the Israeli Ministry ... Scientist (OCS) to support product development and advance ...
Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... Nov. 1, 2010 LitePoint Corporation, the leader in ... Health Alliance, along with other technology leaders. ... of personal healthcare and to establish a system of ... for all people. "Wireless will be ...
... /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: ... largest drugstore chain in China based on the number ... will report its third quarter 2010 financial results on ... The Company will host a conference call, to ...
Cached Medicine Technology:LitePoint Joins Continua Health Alliance 2China Nepstar Chain Drugstore to Report Third Quarter 2010 Financial Results on November 17, 2010 2
(Date:5/24/2013)... City, Utah (PRWEB) May 24, 2013 ... , with exciting new enhancements for instructors and students. ... stay more focused through personalize learning plan templates, targeted ... AnatomyOne release provides 500 new assessment questions, 5,000 searchable ... review notes. , AnatomyOne 2.0 is the ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Dwell ... VP, Brandon Huff as Executive Vice President of Digital ... business units, which represented a large portion of Yahoo's ... growth as Dwell develops a fully-integrated commerce unit to ... of experience monetizing digital content for leading firms in ...
(Date:5/24/2013)... News) -- Low-income, minority parents have more realistic ... more open to vaccinating their daughters against the ... study contends. Conversely, white, middle-class parents are ... daughters, according to researchers from the Boston University ... get an HPV-related cancer each year, many of ...
(Date:5/24/2013)... 2013 The Dictation Source recently added ... clients. As a result of its National marketing efforts, ... 20 states around the nation. , Since 1991, The ... to the healthcare industry . Dictation Source is owned ... years of clinical work experience to provide the solutions ...
(Date:5/24/2013)... 24 (HealthDay News) -- About one in five parents ... take up smoking, drinking or illicit drug use, a ... say experts at the Substance Abuse and Mental Health ... are actually one of the most influential forces helping ... "Surveys of teens repeatedly show that parents can ...
Breaking Medicine News(10 mins):Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Yahoo Commerce Head Joins Leadership at Dwell Media 2Health News:Low-Income, Minority Parents More Open to HPV Vaccine for Girls, Study Says 2Health News:The Dictation Source Signs Two National Hospital Chains 2Health News:The Dictation Source Signs Two National Hospital Chains 3Health News:Parents Underestimate Influence Over Teens' Substance Abuse: Survey 2
... Myeloma ( www.ManagingMyeloma.com ), an accredited ... for fellows in oncology to win a scholarship to ... Meeting in New Orleans, Louisiana. The scholarship includes registration ... for meals. , During the conference, the ...
... ... designed to inform our users that the life saving medications they or their loved ... ... -- Recently, WarrantyElephant met with the founder of AllergySense.com, Rhonda Lewis, a WarrantyElephant user, ...
... ... knee amputee, and world record holder in over 10 events in running and triathlon set ... Spirit of the Prairie 100 mile Trail Run in Cassoday, Kansas, Ms. Palmerio-Winters not only ... and finished in 8th place overall. , , ...
... ZURICH, Switzerland, October 15 ... 17 and 18 October 2009. Medical staff, but,particularly administrators ... exceptional introduction to the latest achievements,in football medicine and ... all levels of play. , ...
... Calif., Oct. 14 Beckman Coulter, Inc. (NYSE: BEC ... Thursday, October 29, 2009, at 5:00 p.m. ET to discuss ... released after the market closes. , (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ... 516-3365 or (706) 679-3246 and asking for the Beckman Coulter ...
... , TACOMA, Wash., Oct. 14 Spectrum Pension Consultants, a ... to announce that the 2009 Spectrum Open raised over $100,000, ... oncology unit at St. Joseph,s Hospital. , "This event was ... a participation and fundraising perspective. It was incredible to watch ...
Cached Medicine News:Health News:Managing Myeloma Website Announces Fellow Scholarship Program to Attend and Report on Annual American Society of Hematology in New Orleans 2Health News:WarrantyElephant Launches "MediElephant" a New Medication Reminder Service Inspired by WarrantyElephant User Rhonda Lewis, Founder of AllergySense 2Health News:First Female Amputee To Run a 100 Mile Trail Run Wins the Race 2Health News:FIFA Medical Conference, 17 and 18 October 2009 in Zurich 2Health News:FIFA Medical Conference, 17 and 18 October 2009 in Zurich 3Health News:4th Annual Spectrum Open: A Big Success 2
Portable shields for your safety and convenience....
Portable shields for your safety and convenience....
... Marshield manufactures standard and custom shields and barriers ... for low level or high level radiation shielding, ... 99.95% pure lead, lead acrylic, lead glass, lead ... materials. We can offer shielding from 1/32" thick ...
Full-Height Radiation Barriers provide full-body shielding and reduce eye strain during extended procedures....
Medicine Products: